J&J

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

Retrieved on: 
Thursday, March 28, 2024
Patient, Chairperson, CNS, Mental health, Innovation, CMPS, Psilocybin, TRD, Johnson & Johnson, Operation, Pain, KCL, Frustration, J&J, Food, Nursing

David Norton, lead independent director on the Compass board of directors, will become interim chair.

Key Points: 
  • David Norton, lead independent director on the Compass board of directors, will become interim chair.
  • Compass is running a global search for a permanent board chair, focused on recruiting a leader with a strong background in the biotechnology sector and broad strategic experience across the product lifecycle.
  • “When we started Compass eight years ago, we could not have imagined how the company would grow and mature,” said George Goldsmith, outgoing board chair of Compass Pathways.
  • He has been a member of the Compass board of directors since 2018, serving as lead independent director.

Johnson & Johnson Expands Commitment to Advance Health Equity

Retrieved on: 
Wednesday, April 3, 2024
Other Health, Research, General Health, Pharmaceutical, Oncology, Medical Devices, Health Technology, Science, Biotechnology, Medical Supplies, Other Science, Health, Community, Organization, White, Health equity, Male, Empathy, Health care, Mortality, City, Spelman College, Johnson & Johnson, Hispanic and Latino Americans, National Association, Student, Nursing, J&J

Johnson & Johnson announced today that it is collaborating with more than 100 community-led health organizations supporting historically marginalized communities across the United States — building on the Company’s multiyear, multimillion-dollar efforts to improve health equity.

Key Points: 
  • Johnson & Johnson announced today that it is collaborating with more than 100 community-led health organizations supporting historically marginalized communities across the United States — building on the Company’s multiyear, multimillion-dollar efforts to improve health equity.
  • Supporting the work of grassroots organizations, community health centers and national associations is integral to identifying and implementing enduring healthcare solutions,” said Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson.
  • Black Women’s Health Imperative aims to empower Black women to take charge of their health through diabetes prevention and self-management classes.
  • J&J recently held a Health Equity Innovation Challenge to support innovative solutions developed by entrepreneurs and start-ups.

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

Retrieved on: 
Monday, April 1, 2024
Banking, Software, General Health, Professional Services, Hardware, Technology, Medical Devices, Other Manufacturing, Health Technology, Finance, Other Technology, Health, Manufacturing, Culture, Boston Scientific, Growth, EVP, Partnership, Patient, Acquisition, Medtronic, H.I.G. Capital, Surgeon, Waters Corporation, CO, J&J, Management

Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition of the Spine division of ZimVie, Inc (“ZimVie”, NYSE: ZIMV).

Key Points: 
  • Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition of the Spine division of ZimVie, Inc (“ZimVie”, NYSE: ZIMV).
  • The acquired business will operate as an independent entity and has been renamed Highridge Medical (“Highridge” or the “Company”).
  • Glen Kashuba will join Highridge as the Chief Executive Officer and Rebecca Whitney will continue as President of Highridge.
  • medical device investments include Augmedics, Vertiflex (acquired by Boston Scientific), Neuwave Medical (acquired by J&J), and Intact Vascular (acquired by Philips).

Legal-Bay Pre-Settlement Funding Reports Johnson & Johnson Talc Powder Settlement Delayed Yet Again

Retrieved on: 
Wednesday, April 3, 2024
Ovarian cancer, Health, News, Starch, J&J, Science, Johnson & Johnson, Inferior vena cava, Talc

NEW BRUNSWICK, N.J., April 3, 2024 /PRNewswire/ -- Legal-Bay, The Pre Settlement Funding Company, announced today that Johnson & Johnson has just scored a win in their efforts to delay and/or outright avoid payouts on the 60,000+ lawsuits they are facing. A federal judge has just ruled that J&J will be given a new chance to argue the scientific evidence previously put forth that has shown a link between usage of their talcum powder and ovarian cancer.

Key Points: 
  • However, several studies dating back to the 1970s have already concluded that talc particles increase a person's chances of developing serious medical issues.
  • To apply for a cash advance lawsuit loan from your anticipated Johnson & Johnson talc baby powder lawsuit settlement, please visit the company's website HERE or call 877.571.0405.
  • They are one of the best lawsuit loan companies when it comes to mass tort litigations, and is currently the #1 talc funding company in the loan settlement industry.
  • Legal-Bay's loan for settlement funding programs are designed to provide immediate cash in advance of a plaintiff's anticipated monetary award.

United Airlines Names Michelle Freyre to Board of Directors

Retrieved on: 
Monday, April 1, 2024
Culture, United Airlines, Beauty, UAL, Empathy, Harvard Business School, PepsiCo, Bloomberg, MBA, Marketing, Johnson & Johnson, J&J, Yale University, Management

CHICAGO, April 1, 2024 /PRNewswire/ -- United Airlines Holdings, Inc. (UAL) announced today that Michelle Freyre is joining its Board of Directors.

Key Points: 
  • CHICAGO, April 1, 2024 /PRNewswire/ -- United Airlines Holdings, Inc. (UAL) announced today that Michelle Freyre is joining its Board of Directors.
  • "Michelle's extensive experience in business and product strategy will make her an excellent addition to our already strong Board of Directors," said United CEO Scott Kirby.
  • "We are excited to welcome Michelle to the Board of Directors and look forward to the valuable insight and experience she will bring to United," said Ted Philip, Chairman of the Board of Directors.
  • "I am honored to join the Board of Directors at United Airlines and contribute my brand-building experience, global perspectives and passion for serving discerning consumers to such an iconic, transformative and prominent brand," said Michelle Freyre.

Digital Experience Veterans, Andrew Arocha and John Anthony, Join Forces to Found DX-ROI

Retrieved on: 
Tuesday, March 26, 2024
Cloud, SCC, ROI, GM, Organization, CVS, Partnership, Cardinal Health, Tony Sanders, Ulta Beauty, JPMorgan Chase, Multimedia, J&J

LAS VEGAS, March 26, 2024 /PRNewswire/ -- Today marks the inception of DX-ROI, a groundbreaking digital consultancy aiming to redefine the landscape of digital transformation.

Key Points: 
  • LAS VEGAS, March 26, 2024 /PRNewswire/ -- Today marks the inception of DX-ROI, a groundbreaking digital consultancy aiming to redefine the landscape of digital transformation.
  • Their mission is clear: to provide organizations with measurable outcomes and enduring value through process-driven digital strategies.
  • Andrew Arocha expressed his enthusiasm for the venture, stating, "I'm incredibly excited and honored to co-found DX-ROI with John.
  • Tony Sanders, Senior Director, Americas Partner Sales at Adobe said "I'm excited to welcome John and Andrew into the Adobe ecosystem.

NaturVet welcomes Phil Bramel as Chief Commercial Officer

Retrieved on: 
Wednesday, March 13, 2024
TSC, Target, Growth, Central Florida, PetSmart, University of Central Florida, Boehringer Ingelheim, University, CCO, Walmart, Family, Marketing, Warner–Lambert, J&J

TEMECULA, Calif, March 13, 2024 /PRNewswire-PRWeb/ -- NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, is pleased to announce Phil Bramel as its new Chief Commercial Officer (CCO). Bramel brings a wealth of retail and sales expertise to the NaturVet family, with an illustrious 36-year career in various leadership roles within the pet health and wellness sector at companies such as Warner-Lambert, Pfizer, J&J, and Boehringer-Ingelheim. In his new role, Bramel will be responsible for driving sales and marketing strategies for NaturVet, including an expansion of the innovative brand's retail presence.

Key Points: 
  • In his new role, Bramel will be responsible for driving sales and marketing strategies for NaturVet, including an expansion of the innovative brand's retail presence.
  • "It is with great enthusiasm that we introduce Phil Bramel as our Chief Commercial Officer," said Geoff Granger , the CEO of The Garmon Corporation and NaturVet.
  • Click to Post: @NaturVet announces Phil Bramel as the new Chief Commercial Officer.
  • "It is an honor to join the NaturVet family, particularly at a time when the company stands poised for significant growth," said Bramel.

Sandoz announces nominations to the Board of Directors and leadership change

Retrieved on: 
Tuesday, March 5, 2024
Remco, J&J, Person, Chemistry, Mechanical, Growth, IMD, Swisscom, University, Lufthansa, Organization, 10x Genomics, Annual general meeting, Erasmus University Rotterdam, Johnson & Johnson, MBA, Gesellschaft mit beschränkter Haftung, Genomics, Retirement, Flexner Report, Harvard Medical School, HST, CFO, Massachusetts Institute of Technology, Merck, Harvard University, Executive Committee, Doctor of Philosophy, Annual, KPMG, Management

Gilbert Ghostine, Sandoz Chairman, said: "Our company evolves, and so does our leadership team.

Key Points: 
  • Gilbert Ghostine, Sandoz Chairman, said: "Our company evolves, and so does our leadership team.
  • I am pleased we can propose exceptional people in science and in business for election to the Board of Directors this year.
  • The new Board talent maintains the complementarity of expertise and experience in the areas relevant to Sandoz.
  • The following persons are recommended for election to the Board of Directors at the Annual General Meeting on April 30, 2024:

Xencor Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 27, 2024
Biotechnology, Pharmaceutical, Health, Oncology, CD20, NSCLC, Cancer, J&J, Immune system, Alanine transaminase, Autoimmune disease, Research, ENPP3, Investment, ALT, PSMA, Cell, Antibody, Autoimmune hepatitis, Safety, Telephone, Vir, Lymphoid leukemia, Rash, Patient, PSA, RECIST, CLDN6, Diagnosis, Prostate-specific antigen, G&A, Workforce, CD28, Prostate cancer, Pharmaceutical industry

Both programs entered Phase 1 clinical development during the fourth quarter of 2023, and Xencor received $20 million in development milestones.

Key Points: 
  • Both programs entered Phase 1 clinical development during the fourth quarter of 2023, and Xencor received $20 million in development milestones.
  • In the fourth quarter of 2023, Xencor completed enrollment in subcutaneous dose-escalation cohorts of a Phase 1 study evaluating plamotamab.
  • Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023
    Cash, cash equivalents, and marketable debt securities totaled $697.4 million as of December 31, 2023, compared to $584.5 million on December 31, 2022.
  • Total revenue for the fourth quarter ended December 31, 2023 was $44.7 million compared to $21.6 million for the same period in 2022.

CBRE Group, Inc. Closes Acquisition of J&J Worldwide Services

Retrieved on: 
Tuesday, February 27, 2024
Other Defense, Professional Services, Contracts, White House, Federal Government, Commercial Building & Real Estate, Defense, Construction & Property, Engineering, REIT, Finance, Military, Public Policy, Government, Manufacturing, Acquisition, Hospital, J&J, CBRE, Arlington Capital Partners, Federation, CBRE Group, Element, Brooke Army Medical Center

CBRE Group, Inc. (NYSE:CBRE) and Arlington Capital Partners today announced CBRE’s completion of its acquisition of J&J Worldwide Services, a leading provider of engineering services, base support operations and facilities maintenance for the U.S. federal government from Arlington, a Washington, D.C.-area private investment firm specializing in government regulated industries.

Key Points: 
  • CBRE Group, Inc. (NYSE:CBRE) and Arlington Capital Partners today announced CBRE’s completion of its acquisition of J&J Worldwide Services, a leading provider of engineering services, base support operations and facilities maintenance for the U.S. federal government from Arlington, a Washington, D.C.-area private investment firm specializing in government regulated industries.
  • J&J primarily serves the U.S. Department of Defense through long-term, fixed-price contracts.
  • It serves such facilities as Brooke Army Medical Center, Walter Reed National Military Medical Center and the United States Naval Academy.
  • “The acquisition is consistent with key elements of our M&A strategy that focus on enhancing our technical services capabilities, increasing revenue resilience and secular growth, and expanding our government client base within our Global Workplace Solutions segment,” said Bob Sulentic, chair & chief executive officer of CBRE.